Strengthen the R&D engine and solidify the foundation for growth! Keyuan Pharmaceutical held a special product development meeting, outlining a blueprint for innovative advancement!


Publish Time:

2025-06-09

Recently, Keyuan Pharmaceutical held a special seminar at its Research Institute, focusing on an in-depth discussion of the company's R&D strategy, project advancement, and operational management. Chairman and President Gao Chunpo, along with the senior management team, heads of the Research Institute, and leaders of various project teams, attended the meeting. The session aimed to optimize R&D management, strengthen quality control, enhance R&D efficiency, and foster a deeper integration of R&D initiatives with the company's overall business strategy—thereby injecting strong momentum into the firm's long-term growth and development.

Recently, Keyuan Pharmaceutical held a special seminar at its Research Institute, focusing on an in-depth discussion of the company's R&D strategy, project advancement, and operational management. Chairman and President Gao Chunpo, along with the senior management team, heads of the Research Institute, and leaders of various project teams, attended the meeting. The session aimed to optimize R&D management, strengthen quality control, enhance R&D efficiency, and foster a deeper integration of R&D efforts with the company's overall strategic goals—thereby injecting strong momentum into the firm's long-term growth and development.

At the meeting, the heads of each project team systematically reported on the progress of their respective R&D projects, highlighted existing challenges, and outlined their next steps. Company leaders commended the R&D team for their milestone achievements, while also emphasizing that, in the face of increasingly stringent drug regulations and the industry’s long development cycles, the company will continue to ramp up its investment in research and innovation. Over the next three to five years, the company plans to launch at least 10 to 15 new products annually, driving growth by leveraging innovation to enhance the company’s competitive edge.

The meeting clearly emphasized that the institute must further refine its project management mechanisms, clearly define responsibility assignments for each phase, and specify project participants, key milestones, and tailored solutions to ensure efficient advancement of R&D efforts. At the same time, R&D personnel are encouraged to adopt a business-oriented mindset, gaining comprehensive insights into critical factors such as project costs, market prices, and customer demands. They should also strategically integrate considerations like production volume, validation implementation, and market promotion strategies, fostering seamless alignment between R&D and commercialization. Additionally, the meeting underscored the importance of integrating environmental protection and safety into the entire R&D process, standardizing hazardous waste management practices, exploring innovative applications like continuous-flow reactions, and driving forward sustainable, eco-friendly development.

At the meeting, Chairman Gao Chunpo encouraged the R&D team to cultivate "extraordinary confidence," thoughtfully balancing challenges and opportunities in their work. He emphasized staying goal-oriented, accurately forecasting key milestones, and ensuring that both R&D progress and quality meet stringent standards. The meeting also called on all employees to adopt a broader perspective, recognizing the vital link between personal development and the company's strategic objectives. By fostering efficient collaboration and driving innovative breakthroughs, everyone was urged to contribute to the mutual growth of the organization and themselves.

Next, the company will continue to strengthen the institute's pivotal role as an innovation engine. By leveraging strategic planning, integrating resources, and upgrading technologies, we will accelerate the implementation of key projects. With a more forward-looking R&D strategy and enhanced execution capabilities, we aim to elevate the quality and efficiency of our R&D system, positioning ourselves at the forefront of the transformative wave sweeping through the pharmaceutical industry.